RTI Surgical OKs $480M sale of OEM business, names new CEO

RTI Surgical shareholders have approved the sale of its original equipment manufacturer business to a private equity firm in a $480 million cash deal, according to a July 15 announcement.

Advertisement

Montagu Private Equity will acquire the OEM business, which develops biologic, metal and synthetic implants. RTI Surgical plans to use the capital to bolster its spine portfolio.

After the transaction closes, RTI Surgical will rebrand as Surgalign Holdings and President and CEO Camille Farhat will retire from the company.

Terry Rich, president of global spine at RTI Surgical, will assume the role as head of the company.

Stuart Simpson will be installed as chairman of the board of directors as Curtis Selquist steps down after closing.

RTI Surgical expects the transaction to close July 20.

More articles on devices:
7D Surgical radiation-free spine surgery system gets European approval
Medtronic to buy Medicrea for 22% above share price: 6 details
2 hospitals with new spine surgery programs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.